August 8, 2023 01:10 PM EDT
Pharma
Marketing

Mar­ket­ingRx roundup: An­a­lyst group finds no ‘ob­vi­ous’ link to GLP-1s and sui­ci­dal ideation; Am­gen de­buts new Pro­lia TV ad

Beth Snyder Bulik

Senior Editor

Last month, the Eu­ro­pean Med­i­cines Agency be­gan look­ing in­to re­ports of sui­ci­dal ideation and thoughts of self-harm by users of GLP-1 med­i­cines such as …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times